HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis

CONCLUSION: These findings suggested that HAND2-AS1 may be a potential therapeutic target and an indicator of early recurrence for HCC.PMID:38465433 | DOI:10.2174/0115680096279597240219055135

Source: Current Cancer Drug Targets - March 11, 2024 Category: Cancer & Oncology Authors: Zheng Song Yu Zhang Wei Luo Chao Sun Caihong Lv Sihao Wang Quanwei He Ran Xu Zhaofang Bai Xiujuan Chang Yongping Yang Source Type: research